Drug companies are blocking or delaying the entry of cheaper generic medicines into the EU, pushing up medicine bills, the European Commission has said.
Their actions cost EU healthcare providers 3bn euros ($3.9bn; £2.5bn) in savings between 2000 and 2007, it said.
Drug firms 'block cheap medicine'
Air in the U.S. has gotten cleaner for decades, adding years to people's lives and preventing...
The US supreme court on Monday heard arguments in a case that could threaten Americans’ access...
